Latest Breaking News On - Pharmaceuticals stock down - Page 11 : vimarsana.com

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Rating Reaffirmed by Needham & Company LLC

Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Rating Reaffirmed by Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Tina marriottBlake borgesonNews ratings for recursion pharmaceuticals dailyRecursion pharmaceuticals incSecurities exchange commissionRecursion pharmaceuticals stock downInsider activity at recursion pharmaceuticalsSumitomo mitsui trust holdings incVanguard group incHedge funds weigh in on recursion pharmaceuticalsAnalyst recommendations for recursion pharmaceuticalsRecursion pharmaceuticalsNeedham companyMubadala investment coInvestment managementGet free report

Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38 00

Citigroup Raises Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $38 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesEric bjerkholtStifel nicolausPeter radovichMirae asset global investments coMirum pharmaceuticals incNews ratings for mirum pharmaceuticals dailyCantor fitzgeraldWilliam blair investment managementAnalyst recommendations for mirum pharmaceuticalsMirum pharmaceuticals stock downSecurities exchange commissionMirum pharmaceuticals company profileRussell investments group ltdMirum pharmaceuticalsChina universal asset management co

Recursion Pharmaceuticals (NASDAQ:RXRX) Receives Buy Rating from Needham & Company LLC

Recursion Pharmaceuticals (NASDAQ:RXRX) Receives Buy Rating from Needham & Company LLC
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Blake borgesonChristopher gibsonRecursion pharmaceuticalsVanguard group incAnalyst recommendations for recursion pharmaceuticalsNeedham companyInterchange capital partnersKingsview wealth managementSecurities exchange commissionRecursion pharmaceuticals stock downRecursion pharmaceuticals incNews ratings for recursion pharmaceuticals dailyRecursion pharmaceuticals company profileInstitutional investors weigh in on recursion pharmaceuticalsGet free reportPharmaceuticals stock down

Insider Selling: Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Director Sells $256,260 00 in Stock

Insider Selling: Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Director Sells $256,260 00 in Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandUnited statesPiper sandlerNorges bankWells fargo companyIonis pharmaceuticals incIonis pharmaceuticalsIonis pharmaceuticals stock downNeedham companyWellington management groupNews ratings for ionis pharmaceuticals dailySecurities exchange commissionCalifornia public employees retirement systemQuarter for ionis pharmaceuticalsJpmorgan chase co

Xenon Pharmaceuticals (NASDAQ:XENE) Announces Earnings Results, Beats Estimates By $0 07 EPS

Xenon Pharmaceuticals (NASDAQ:XENE) Announces Earnings Results, Beats Estimates By $0 07 EPS
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Steven gannonSherrington robinInsider transactions at xenon pharmaceuticalsXenon pharmaceuticals incXenon pharmaceuticalsEarnings history for xenon pharmaceuticalsNeedham companyRoyal bankCantor fitzgeraldSecurities exchange commissionNews ratings for xenon pharmaceuticals dailyXenon pharmaceuticals stock downGet free reportPharmaceuticals stock downDirector steven gannonExchange commission